Large Molecule Drugs

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Technical Challenges

  • Thermal sensitivity and cold-chain dependence limit field distribution and prolonged storage.

  • Complex and time-consuming manufacturing hampers rapid scale-up for emergent military threats.

  • Delivery barriers — vascular access, mucosal/microenvironmental barriers, and need for field-friendly administration.

  • Immunogenicity, off-target effects, and safety monitoring in polytrauma or immunocompromised Warfighters.

  • Regulatory and quality-assurance constraints for accelerated deployment in austere settings.

Emerging Opportunities

  • Room-temperature stable formulations and compact cold-chain alternatives for prolonged storage.

  • Rapid, deployable manufacturing platforms (portable bioreactors, cell-free synthesis) for surge production.

  • Field-adapted delivery systems (autoinjectors, inhaled/aerosolized, microneedle patches) compatible with prolonged care.

  • Companion diagnostics and decision-support tools to match biologic therapy to pathogen or host phenotype.

  • Standardized bridging pathways for emergency use and transition from research to operational use.

Current and Emerging Technologies in Large Molecule Drugs

Recombinant expression and cell-free synthesis

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Monoclonal antibody and engineered biologic platforms

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Nucleic-acid therapeutics and delivery systems

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Stabilization and formulation innovations

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Point-of-care diagnostics and companion assays

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Importance to Military Medicine

Combat casualty care and toxin neutralization

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Prolonged and distributed care

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Infectious disease and biodefense readiness

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Force readiness and recovery

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Alignment with the MTEC Mission

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Dual-Use (Military + Civilian) Applications

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

Explore MTEC Members with Large Molecule Drugs Capabilities

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

[@portabletext/react] Unknown block type "text", specify a component for it in the `components.types` prop

74 Members with Large Molecule Drugs capabilities.

Member
Georgia Southern University

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

Member
STAT Therapeutics

STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.

Member
Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat antibiotic-resistant and difficult-to-treat bacterial infections. With a focus on addressing the global antibiotic resistance crisis, Armata leverages its proprietary bacteriophage-based technology to develop high-impact, best-in-class phage therapeutics. The company operates from a 56,000 square foot facility in Los Angeles, California, equipped for phage product development from bench to clinic. Armata's team of microbiologists and scientists work on discovering natural phages and enhancing them through synthetic biology and engineering to create tailored drug products for clinical trials.

Member
Auburn University

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

Member
University of Arkansas

The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.

Member
Action Medical Technologies

Action Medical Technologies is a pharmaceutical and medical device company focused on developing innovative solutions that integrate medications with advanced devices and injector systems to improve patient outcomes, particularly in austere prehospital environments.

Member
Vindhya Data Science

Vindhya Data Science is a women-owned small business headquartered in North Carolina, USA, with a presence in RTP and Boston. We specialize in bioinformatics, genomics, artificial intelligence, and data engineering, cheminformatics, evidence-based medicine, epidemiology and related disciplines. Vindhya partners with federal government agencies, leading academic medical centers, and pharma/biotech organizations to transform large datasets into informed decisions using advanced data science technologies. With over 100 years of combined experience, 150+ publications, and 73+ successful projects, Vindhya is committed to delivering impactful solutions in the life sciences sector.

Member
The University of Chicago

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Member
Memsel

Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.

Member
Boston University

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

Member
Baylor University

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

Member
Evimero

Evimero is an interdisciplinary company focused on understanding the interactions between microorganisms and human health, agriculture, and the environment, utilizing Systems Biology and AI/ML. Evimero applies molecular principles to infectious disease and microbiome science to improve health outcomes and environmental sustainability through targeted interventions in dysbiotic microbiomes and in people with infectious disorders. Evimero has an infectious disease product pipeline including both prophylactic and diagnostic assets against common causes of Travelers' Diarrhea, including a unique approach to preventing infection with human Norovirus, enterotoxigenic E. coli (ETEC) and others. Evimero's pipeline of drugs targeting human and animal microbiomes includes early-stage assets aimed at generalized microbiome-driven inflammation and gut leak, and specific disease-targeted disorders including Parkinson Disease and Inflammatory Bowel Diseases. Evimero's platform also makes possible a suite of point-of-care diagnostics that can be used for patient cohorting (infectious diseases), risk stratification, and ultimately informing therapeutic decision-making. The nature of Evimero's platform assures a steady stream of novel assets targeting both infectious diseases and chronic disorders with roots in microbiome dysfunction.

Member
Kane Biotech

Kane Biotech is a Canadian-based biotechnology company focused on the research, development, and commercialization of products that prevent and remove microbial biofilms. Established in 2001, the company aims to improve human and animal welfare through innovative solutions to biofilm-related challenges and antimicrobial resistance. With a strong portfolio of 54 patents and patents pending, Kane Biotech is recognized as a leader in biofilm research and technology, and is listed on the TSX Venture Exchange under the symbol 'KNE' and on the OTC Markets under the symbol 'KNBIF'.

Member
Purgo Scientific

Purgo Scientific is a medical device company dedicated to developing effective solutions for the biofilm infections crisis in orthopedic surgery. Their mission is to provide a locally targeted sustained delivery device that ensures the right therapy is delivered to the right place for the right duration, ultimately improving patient outcomes and reducing the impact of surgical site infections.

Member
University of North Carolina Wilmington

The University of North Carolina Wilmington (UNCW) is a top doctoral and research institution located in Wilmington, North Carolina. Established in 1947, UNCW has grown to serve nearly 18,000 students and employs about 2,500 staff. The university is dedicated to providing a powerful academic experience that fosters creative inquiry, critical thinking, and thoughtful expression in a beautiful coastal setting. UNCW is committed to educational excellence, community engagement, and global connections, making it a vibrant part of the southeastern North Carolina community. UNCW also emphasizes the importance of freedom of expression and mutual respect within its diverse community.

Member
University of Missouri-Kansas City

The University of Missouri-Kansas City (UMKC) is dedicated to transforming today's learners into tomorrow's leaders through innovative education, research, and community engagement. With over 125 academic programs, UMKC fosters a diverse and inclusive environment that empowers students to achieve their goals and make a positive impact in their communities.

We are here to help

Can’t find what you’re looking for?

Projects

Technology Showcase

See All Projects

University of California San Francisco

TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness

TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.

Arizona State University

ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience

Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.

University of Pittsburgh

Topical Metformin Lotion for Tendinopathy Prevention

University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.

Theradaptive

Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE

Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.